Bone Marrow and Wharton’s Jelly Mesenchymal Stromal Cells are Ineffective for Myocardial Repair in an Immunodeficient Rat Model of Chronic Ischemic Cardiomyopathy

BACKGROUND: Although cell therapy provides benefits for outcomes of heart failure, the most optimal cell type to be used clinically remains unknown. Most of the cell products used for therapy in humans require in vitro expansion to obtain a suitable number of cells for treatment; however, the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xian-Liang, Nasr, Marjan, Zheng, Shirong, Zoubul, Taylor, Stephan, Jonah K., Uchida, Shizuka, Singhal, Richa, Khan, Aisha, Gumpert, Anna, Bolli, Roberto, Wysoczynski, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579184/
https://www.ncbi.nlm.nih.gov/pubmed/37500831
http://dx.doi.org/10.1007/s12015-023-10590-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579184/
https://www.ncbi.nlm.nih.gov/pubmed/37500831
http://dx.doi.org/10.1007/s12015-023-10590-6

Ejemplares similares